Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Wharton's Jelly-derived Stem Cells in Patients With Osteoarthritis of the Knee, Hip or Glenohumeral Joint and Analysis of the Regeneration Processes Based on Inflammatory Markers, microRNAs and Clinical Features

NCT03866330 is registered in ClinicalTrials.gov with Medical University of Warsaw as lead sponsor.

NCT NCT03866330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03866330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Wharton's Jelly-derived Stem Cells in Patients With Osteoarthritis of the Knee, Hip or Glenohumeral Joint and Analysis of the Regeneration Processes Based on Inflammatory Markers, microRNAs and Clinical Features
Lead sponsor
Medical University of Warsaw
Phase
Phase 1/2
Overall status
Unknown status
Start date
March 1, 2019
Completion date
March 1, 2022
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glenohumeral osteoarthritis, hip osteoarthritis, knee osteoarthritis, osteoarthritis